🇺🇸 FDA
Pipeline program

Part 1

ZYN2-CL-007

Phase 1 small_molecule completed

Quick answer

Part 1 for Drug Interaction is a Phase 1 program (small_molecule) at Harmony Biosciences Holdings with 1 ClinicalTrials.gov record(s).

Program details

Company
Harmony Biosciences Holdings
Indication
Drug Interaction
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials